Abstract
Clinical science in the field of infectious diseases moved at a rapid pace in 2024. Among the highlights were multiple trials of new antibiotics and new approaches to prevent infections. Concerning trends, with outbreaks of dengue, measles, mpox, and highly pathogenic avian influenza A in 2024, demonstrate the importance of infectious diseases and the continued need for further advances through clinical science. This review highlights some of the most important trials and clinical trends in infectious diseases over the past year.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have